(E)-1-(5-Methoxy-2,2-dimethyl-2H-chromen-8-yl)-3-(4-methoxyphenyl)prop-2-en-1-one, 97.0%, 10mg

2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-ol, 95%, 100mg

(4-Chloro-phenyl)-piperidin-4-yl-amine, 50mg

methyl 3-aminobicyclo[1.1.1]pentane-1-carboxylate, 97.0%, 500mg

Phenyl(3-phenyloxiran-2-yl)methanone, 98%, 200mg

4-chloro-2-ethyl-6-methylpyrimidine, 95.0%, 100mg

(3R,5R)-3,5-DIMETHYL-4-PHENYLPIPERIDIN-4-OL, 95.0%, 1g

Methyl 1H-pyrrolo[3,2-b]pyridine-6-carboxylate, 95.0%, 25g

(2,3-Dihydro-benzo[1,4]dioxin-5-yl)-(3-methyl-piperazin-1-yl)-methanone hydrochloride, 95.0%, 250mg

2-Cyclopropylbenzoic acid, 95.0%, 100mg

Recipiente de reacción con brida plana cilíndrico, graduado (1) Fondo redondo, DN 150, 160 mm, Altura, 210 mm, 1 Pieza

9-Methyladenine, 95.0%, 100mg

2-Chloro-1-methoxy-3-nitrobenzene, 95.0%, 100g